Table 2.
Logistic regression model in 427 patients with HIV/HBVco-infection according to anti-HBV treatment status
| |
Never treated vs treated patients adjusted OR |
|
|---|---|---|
| Characteristics | (95% CI) | P |
| N. enrolled per center§ |
|
|
| ≥20 patients |
1.41 (0.73-2.71) |
0.31 |
| Female gender |
0.83 (0.39-1.77) |
0.64 |
| Immigrant status |
|
|
| Foreign birth |
0.74 (0.3-1.8) |
0.51 |
| Age at diagnosis |
|
|
| 10 years increase |
0.78 (0.55-1.11) |
0.17 |
| Years since diagnosis* |
|
<0.001 |
| 2-10 |
0.17 (0.08-0.36) |
|
| <10 |
0.08 (0.03-0.25) |
|
| Alcohol consumption |
|
|
| Ever |
1.51 (0.63-3.62) |
0.35 |
| Disease stage° |
|
|
| cirrhosis/HCC |
0.39 (0.09-1.78) |
0.22 |
| HBeAg |
|
|
| positivity |
0.57 (0.28-1.14) |
0.11 |
| HCV co-infection |
|
|
| yes |
0.91 (0.41-2.02) |
0.82 |
| HDV co-infection |
|
|
| yes | 0.48 (0.14-1.66) | 0.25 |
Reference: § = ≤20 patients enrolled; * = <2 years;° = chronic hepatitis. OR, odds ratio; CI, confidence interval; HCC, hepatocellular carcinoma.